Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose

Clinical trial NCT00891813 · COMPLETED

Trial details

NCT number: NCT00891813
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Secondary Hyperparathyroidism Renal Insufficiency, Chronic Parathyroid Hormone Hemodialysis Hypercalcemia

Start date: 2009-05-01
Primary completion: 2010-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.